AR and Kennedy disease: In this study, we evaluated whether a combined pharmacological treatment, aimed both to reduce the nuclear toxicity exerted by mutant AR and to enhance its autophagic clearance, may be of use as a novel therapeutic approach in SBMA (21,30,34,50).